- Efficacy and safety of regorafenib or fruquintinib plus camrelizumab …
Number of the records: 1  

Efficacy and safety of regorafenib or fruquintinib plus camrelizumab in patients with microsatellite stable and/or proficient mismatch repair metastatic colorectal cancer: an observational pilot study

  1. TitleEfficacy and safety of regorafenib or fruquintinib plus camrelizumab in patients with microsatellite stable and/or proficient mismatch repair metastatic colorectal cancer: an observational pilot study / Feng-E Jiang ... [et al.]
    Another responsib. Jiang, Feng-E (Author)
    Phys.des.ilustr., obr., tab.
    NoteBibliogr. odkazy. Res. angl.
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 68, no. 4 (2021), s. 861-866
    Call numberC 720
    MeSH Subject nádory kolorektálne - farmakoterapia
    farmakoterapia kombinovaná - metódy
    účinky liekov vedľajšie a nežiaduce reakcie liekov
    Keywords nádory kolorektálne metastatatické * kombinácia regorafenib a camrelizumab * kombinácia frukvintinib a camrelizumab * vyhodnotenie súboru pacientov
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.